Park Avenue Securities’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.31M Buy
105,029
+44,499
+74% +$1.4M 0.03% 417
2025
Q4
$1.78M Buy
+60,530
New +$1.68M 0.02% 588
2025
Q2
Sell
-11,653
Closed -$267K 1558
2025
Q1
$267K Buy
11,653
+3,063
+36% +$73.9K ﹤0.01% 1039
2024
Q4
$217K Sell
8,590
-2,223
-21% -$56.3K ﹤0.01% 1407
2024
Q3
$270K Sell
10,813
-3,803
-26% -$113K ﹤0.01% 1221
2024
Q2
$433K Buy
14,616
+1,240
+9% +$34.4K 0.01% 1029
2024
Q1
$403K Buy
13,376
+1,764
+15% +$48.9K 0.01% 1057
2023
Q4
$332K Sell
11,612
-3,862
-25% -$113K ﹤0.01% 1081
2023
Q3
$573K Buy
15,474
+789
+5% +$30.1K 0.01% 784
2023
Q2
$573K Buy
14,685
+1,952
+15% +$76.5K 0.01% 611
2023
Q1
$465K Buy
12,733
+734
+6% +$23.2K 0.01% 611
2022
Q4
$370K Buy
+11,999
New +$372K 0.01% 891

Other funds holding RTO

Park Avenue Securities's RTO Position: Q1 2026 in Review

Park Avenue Securities increased its Rentokil (RTO) stake by 74% in Q1 2026, buying an estimated $1.4M and bringing the position to 105,029 shares worth $3.31M. The position accounts for 0.03% of the portfolio, ranked #417.

Park Avenue Securities first reported a position in RTO in Q4 2022 and has held it in 12 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Park Avenue Securities held 105,029 shares of Rentokil worth $3.31M as of Q1 2026.
  • Park Avenue Securities bought 44,499 Rentokil shares in Q1 2026, an estimated $1.4M.
  • Rentokil made up 0.03% of Park Avenue Securities's portfolio in Q1 2026, its #417 holding.
  • Park Avenue Securities first reported a position in Rentokil in Q4 2022 and has held it in 12 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Park Avenue Securities's 13F filing for Q1 2026, filed 7 Apr 2026.